+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Ventricular Assist Device Market Size, Share & Trends Analysis Report by Product (LVAD, RVAD, BiVAD, TAH), by Type of Flow (Pulsatile, Continuous), by Design, by Application, by Region, and Segment Forecasts, 2020 - 2027

  • ID: 3640136
  • Report
  • February 2020
  • Region: Global
  • 150 pages
  • Grand View Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott
  • Abiomed
  • Berlin Heart
  • Cardiac Assist, Inc.
  • Jarvik Heart, Inc.
  • Medtronic
  • MORE
The global ventricular assist device market size is expected to reach USD 4.1 billion by 2027, according to this report registering a CAGR of 11.7% over the forecast period. Increase in prevalence of cardiovascular diseases such as congenital heart diseases, heart failure, hypertension, ventricular septal defect, and stroke due to rise in adoption of unhealthy lifestyle habits such as physical inactivity, smoking, and alcohol consumption drives the demand for ventricular assist devices (VADs). Increase in global geriatric population, along with their susceptibility to cardiovascular diseases, is a major factor driving the market growth. According to estimates published by the United Nations in 2012, the global geriatric population was nearly 809.4 million and is expected to witness a twofold increase by 2050 with an estimated population of over 2,000 million. Geriatric population has a high risk of various cardiovascular diseases and a majority of them are expected to suffer from heart failure or stroke.

Moreover, the use of VADs as a bridge to transplant is gaining immense popularity due to improvements in device technology and reduction of VAD-associated complications. For instance, the United Kingdom National Health Service (UK NHS) financed a bridge-to-transplant (BTT) program in which left ventricular assist devices (LVADs) such as HeartMate II and HeartWare are used for treating patients.

According to data published by the CDC in 2015, nearly 1.0% newborns have congenital heart defect (CHD) in U.S. and of those 25.0% of the infants have critical CHD. Furthermore, it is estimated that approximately 1,755 infants with critical CHDs remain undiagnosed. The demand for VADs is primarily driven by the increasing prevalence of CHD, especially cyanotic CHD in adult population. The increasing patient pool for cardiovascular disorders, coupled with growing demand for mechanical assist devices, is expected to drive the demand for VADs over the forecast period. However, high costs of these products, limited insurance coverage, and strict regulatory framework for their approval are some of the barriers limiting market growth.

Further key findings from the report suggest:
  • Left ventricular assist devices emerged as the largest product segment in 2019 with a share of 76.9% in the global ventricular assist device market. This is attributed to the increasing demand for LVADs in bridge-to-transplantation for patients suffering from end-stage heart failure
  • On the basis of type of flow, continuous flow accounted for the largest share in 2019, and is further projected to register the highest CAGR over the forecast period as these devices require low maintenance and replacement
  • Implantable VAD emerged as the leading design type segment in 2019 owing to the increasing preference for long-term treatment methods
  • Destination therapy is expected to register a significant growth rate over the forecast period owing to the increasing instances of cardiovascular diseases
  • North America dominated the global VAD market in 2019 owing to the presence of majority of the global obese population, which is one of the key factors leading to the rise in cardiovascular diseases
  • Key operating players such as Abiomed, Abbott, Medtronic, Cardiac Assist, Inc., Berlin Heart, and ReliantHeart focus on developing advanced VADs. For instance, in October 2018, Abbott received U.S. FDA approval for Heartmate 3 - LVAD. This pump would help heart failure patients to avoid open heart surgery.

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott
  • Abiomed
  • Berlin Heart
  • Cardiac Assist, Inc.
  • Jarvik Heart, Inc.
  • Medtronic
  • MORE
Chapter 1 Research Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 Internal Database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 List of Secondary Sources
1.5 List of Primary Sources
1.6 Information or Data Analysis
1.6.1 Data analysis models
1.7 Market Formulation & Validation
1.8 Model Details
1.8.1 Company market share analysis (model 1)
1.8.1.1 Approach 1: Commodity Flow Approach
1.8.1.2 Global Market: CAGR Calculation
1.9 Abbreviations
1.10 Report Objectives

Chapter 2 Executive Summary
2.1 Market Outlook
2.1.1 Ventricular assist device market outlook, 2016 - 2027 (USD Million)
2.2 Segment Outlook
2.3 Competitive Outlook
2.4 Ventricular Assist Device Market Summary, 2019

Chapter 3 Ventricular Assist Device Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market analysis
3.1.2 Ancillary market analysis
3.2 Penetration & Growth Prospect Mapping
3.3 Pricing Analysis
3.4 Product Pipeline Analysis
3.5 Industry Analysis
3.5.1 Consumer behavior analysis
3.5.2 Market influencer analysis
3.5.2.1 North America
3.5.2.2 Europe
3.5.2.3 Asia Pacific
3.5.2.4 Latin America
3.5.2.5 MEA
3.5.3 List of key end users, by product
3.6 Technology Timeline Overview
3.6.1 Technology timeline ventricular assist device market changing technology & adoption
3.7 Regulatory Framework
3.7.1 Reimbursement framework
3.7.2 Standards & compliance
3.7.2.1 CPT Coding implications
3.7.2.2 HCPCS Coding implications
3.7.2.3 ICD-10-CM Coding implications
3.7.3 Safety
3.8 Ventricular Assist Device Market Dynamics
3.8.1 Market driver analysis
3.8.1.1 Increasing prevalence of cardiovascular diseases
3.8.1.2 Technological advancements pertaining to novel product development
3.8.1.3 Shortage of transplant organs
3.8.2 Market restraint analysis
3.8.2.1 High procedure cost
3.8.2.2 Insurance coverage is limited in emerging countries
3.8.3 Industry challenges
3.8.3.1 Development of small, affordable and efficient devices
3.9 Ventricular Assist Device Market Analysis Tools
3.9.1 Industry analysis - Porter’s
3.9.1.1 Supplier power
3.9.1.2 Buyer power
3.9.1.3 Threat of substitutes
3.9.1.4 Threat of New entrants
3.9.1.5 Competitive rivalry
3.9.2 PESTEL analysis
3.9.2.1 Political landscape
3.9.2.2 Economic landscape
3.9.2.3 Social landscape
3.9.2.4 Technology landscape
3.9.2.5 Environmental landscape
3.9.2.6 Legal landscape
3.9.3 Major deals & strategic alliances analysis
3.9.3.1 Mergers & acquisitions
3.9.3.2 Product launch
3.9.3.3 Expansion
3.9.4 Partnerships & collaborations
3.9.5 Case study

Chapter 4 Ventricular Assist Device Market: Competitive Analysis
4.1 Market Participation Categorization
4.1.1 Regional network map
4.1.2 Innovators
4.1.3 Market leaders
4.1.4 Key company market share analysis, 2018
4.1.4.1 Abbott
4.1.4.2 Abiomed
4.1.5 Company market share by region, 2018
4.2 Public Companies
4.2.1 Company market position analysis
4.2.2 Heat map analysis
4.3 Private Companies
4.3.1 List of emerging companies in VAD market space
4.3.2 Heat map analysis
4.4 Vendor Landscape
4.4.1 List of key distributors and channel partners
4.4.2 Key customers
4.4.3 Funding outlook

Chapter 5 Ventricular Assist Device Market: Product Estimates & Trend Analysis
5.1 Definitions & Scope
5.2 Global Ventricular Assist Devices Market: Product Market Share Analysis, 2019 and 2027
5.3 Left ventricular assist devices
5.3.1 Left ventricular assist devices analysis market estimates and forecasts, 2016 - 2027 (USD million)
5.4 Right ventricular assist devices
5.4.1 Right ventricular assist devices analysis market estimates and forecasts, 2016 - 2027 (USD million)
5.5 Bi-ventricular assist devices
5.5.1 Bi-ventricular assist devices analysis market estimates and forecasts, 2016 - 2027 (USD million)
5.6 Total artificial heart
5.6.1 Total artificial heart analysis market estimates and forecasts, 2016 - 2027 (USD million)

Chapter 6 Ventricular Assist Device Market: Type Of Flow Estimates & Trend Analysis
6.1 Definitions & Scope
6.2 Global Ventricular Assist Devices Market: Type of Flow Market Share Analysis, 2019 and 2027
6.3 Pulsatile flow
6.3.1 Pulsatile flow analysis market estimates and forecasts, 2016 - 2027 (USD million)
6.4 Continuous flow
6.4.1 Continuous flow analysis market estimates and forecasts, 2016 - 2027 (USD million)

Chapter 7 Ventricular Assist Device Market: Design Estimates & Trend Analysis
7.1 Definitions & Scope
7.2 Global Ventricular Assist Devices Market: Design Market Share Analysis, 2019 and 2027
7.3 ImplanTable ventricular assist devices
7.3.1 ImplanTable ventricular assist devices analysis market estimates and forecasts, 2016 - 2027 (USD million)
7.4 Transcutaneous ventricular assist devices
7.4.1 Transcutaneous ventricular assist devices analysis market estimates and forecasts, 2016 - 2027 (USD million)

Chapter 8 Ventricular Assist Device Market: Application Estimates & Trend Analysis
8.1 Definitions & Scope
8.2 Global Ventricular Assist Devices Market: Application Market Share Analysis, 2019 and 2027
8.3 Bridge to transplantation
8.3.1 Bridge to transplantation analysis market estimates and forecasts, 2016 - 2027 (USD million)
8.4 Destination therapy
8.4.1 Destination therapy analysis market estimates and forecasts, 2016 - 2027 (USD million)
8.5 Bridge to recovery & Bridge to candidacy
8.5.1 Bridge to recovery & Bridge to candidacy analysis market estimates and forecasts, 2016 - 2027 (USD million)

Chapter 9 Ventricular Assist Device Market: Regional Estimates & Trend Analysis, By Product, Type Of Flow, Design & Application
9.1 Global Ventricular assist devices Market: Regional Movement Analysis
9.2 North America
9.2.1 Market estimates and forecasts by product type, type of flow, design and application, 2016 - 2027 (USD Million)
9.2.2 U.S.
9.2.2.1 Market estimates and forecasts by product type, type of flow, design and application, 2016 - 2027 (USD Million)
9.2.3 Canada
9.2.3.1 Market estimates and forecasts by product type, type of flow, design and application, 2016 - 2027 (USD Million)
9.3 Europe
9.3.1 Market estimates and forecasts by product type, type of flow, design and application, 2016 - 2027 (USD Million)
9.3.2 Germany
9.3.2.1 Market estimates and forecasts by product type, type of flow, design and application, 2016 - 2027 (USD Million)
9.3.3 U.K.
9.3.3.1 Market estimates and forecasts by product type, type of flow, design and application, 2016 - 2027 (USD Million)
9.3.4 France
9.3.4.1 Market estimates and forecasts by product type, type of flow, design and application, 2016 - 2027 (USD Million)
9.3.5 Spain
9.3.5.1 Market estimates and forecasts by product type, type of flow, design and application, 2016 - 2027 (USD Million)
9.3.6 Italy
9.3.6.1 Market estimates and forecasts by product type, type of flow, design and application, 2016 - 2027 (USD Million)
9.3.7 Russia
9.3.7.1 Market estimates and forecasts by product type, type of flow, design and application, 2016 - 2027 (USD Million)
9.4 Asia Pacific
9.4.1 Market estimates and forecasts by product type, type of flow, design and application, 2016 - 2027 (USD Million)
9.4.2 China
9.4.2.1 Market estimates and forecasts by product type, type of flow, design and application, 2016 - 2027 (USD Million)
9.4.3 Japan
9.4.3.1 Market estimates and forecasts by product type, type of flow, design and application, 2016 - 2027 (USD Million)
9.4.4 India
9.4.4.1 Market estimates and forecasts by product type, type of flow, design and application, 2016 - 2027 (USD Million)
9.4.5 South Korea
9.4.5.1 Market estimates and forecasts by product type, type of flow, design and application, 2016 - 2027 (USD Million)
9.4.6 Singapore
9.4.6.1 Market estimates and forecasts by product type, type of flow, design and application, 2016 - 2027 (USD Million)
9.4.7 Australia
9.4.7.1 Market estimates and forecasts by product type, type of flow, design and application, 2016 - 2027 (USD Million)
9.5 Latin America
9.5.1 Market estimates and forecasts by product type, type of flow, design and application, 2016 - 2027 (USD Million)
9.5.2 Brazil
9.5.2.1 Market estimates and forecasts by product type, type of flow, design and application, 2016 - 2027 (USD Million)
9.5.3 Mexico
9.5.3.1 Market estimates and forecasts by product type, type of flow, design and application, 2016 - 2027 (USD Million)
9.5.4 Argentina
9.5.4.1 Market estimates and forecasts by product type, type of flow, design and application, 2016 - 2027 (USD Million)
9.6 MEA
9.6.1 Market estimates and forecasts by product type, type of flow, design and application, 2016 - 2027 (USD Million)
9.6.2 Saudi Arabia
9.6.2.1 Market estimates and forecasts by product type, type of flow, design and application, 2016 - 2027 (USD Million)
9.6.3 UAE
9.6.3.1 Market estimates and forecasts by product type, type of flow, design and application, 2016 - 2027 (USD Million)
9.6.4 South Africa
9.6.4.1 Market estimates and forecasts by product type, type of flow, design and application, 2016 - 2027 (USD Million)
9.7 SWOT Analysis, by Region
9.7.1 North America
9.7.2 Europe
9.7.3 Asia Pacific
9.7.4 Latin America
9.7.5 Middle East & Africa

Chapter 10 Company Profiles
10.1 Abiomed
10.1.1 Company overview
10.1.2 Financial performance
10.1.3 Product benchmarking
10.1.4 Strategic initiatives
10.2 Medtronic
10.2.1 Company overview
10.2.2 Financial performance
10.2.3 Product benchmarking
10.2.4 Strategic initiatives
10.3 Abbott
10.3.1 Company overview
10.3.2 Financial performance
10.3.3 Product benchmarking
10.3.4 Strategic initiatives
10.4 Berlin Heart
10.4.1 Company overview
10.4.2 Product benchmarking
10.4.3 Strategic initiatives
10.5 Cardiac Assist, Inc.
10.5.1 Company overview
10.5.2 Product benchmarking
10.5.3 Strategic initiatives
10.6 Jarvik Heart, Inc.
10.6.1 Company overview
10.6.2 Product benchmarking
10.6.3 Strategic initiatives
10.7 ReliantHeart, Inc.
10.7.1 Company overview
10.7.2 Product benchmarking
10.7.3 Strategic initiatives
10.8 Sun Medical Technology Research Corp.
10.8.1 Company overview
10.8.2 Product benchmarking
10.8.3 Strategic initiatives
10.9 KOL Commentary


*Full List of Tables and Figures Available on Enquiry.
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abiomed
  • Medtronic
  • Abbott
  • Berlin Heart
  • Cardiac Assist, Inc.
  • Jarvik Heart, Inc.
  • ReliantHeart, Inc.
  • Sun Medical Technology Research Corp.
Note: Product cover images may vary from those shown
Adroll
adroll